It is also noteworthy that the combination of ALDH2 inhibition and anti‐PD‐1 antibody enhances antitumor immunity and tumor eradication, which may serve as a novel strategy to enhance the efficacy of immune checkpoint blockade in CRC patients, especially in those who consumed alcohol.295. The gene discussed is ALDH2; the disease is colorectal carcinoma.